Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 6/2007

01-06-2007 | Case Report

Necrotizing fasciitis resulting from Streptococcus pneumoniae in recently diagnosed systemic lupus erythematosus case: a case report

Authors: A. Isik, S. S. Koca

Published in: Clinical Rheumatology | Issue 6/2007

Login to get access

Abstract

Systemic lupus erythematosus (SLE) is a systemic, autoimmune disease. SLE patients are prone to infections, and their hospital admissions and mortality are most commonly associated with infections. Necrotizing fasciitis (NF) is a rare, life-threatening infection of the subcutaneous tissue. In this report, NF associated with Streptococcus pneumoniae (SPN) that developed within hours and resulted in death is presented in a 46-year-old female case who was recently diagnosed as SLE and did not receive any medication (steroid, immunosuppressive, etc.) except for etodolac. This case shows that SLE can generate predisposition to NF, and SPN can play a role in NF etiology.
Literature
1.
Petri MA (2005) Systemic lupus erythematosus: pathogenesis. In: Kppman WJ, Moreland LW (eds) Arthritis and allied conditions: a textbook of rheumatology, 15th edn. Williams & Wilkins, Philadelphia, pp 1473–1497
2.
Nived O, Sturfelt G, Wollheim F (1985) Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group. Q J Med 55(218):271–287PubMed
3.
Le Moing V, Leport C (1998) Infections and lupus. Rev Prat 48:637–642PubMed
4.
Rojas-Serrano J, Cardiel MH (2000) Lupus patients in an emergency unit. Causes of consultation, hospitalization and outcome. A cohort study. Lupus 9:601–606CrossRefPubMed
5.
Petri M, Genovese M (1992) Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of Hopkins lupus cohort. J Rheumatol 19:1559–1565PubMed
6.
Schutze GE, Mason EO Jr, Barson WJ, Kim KS, Wald ER, Givner LB et al (2002) Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J 21(4):278–282CrossRefPubMed
7.
Ballon-Landa GR, Gherardi G, Beall B, Krosner S, Nizet V (2001) Necrotizing fasciitis due to penicillin-resistant Streptococcus pneumoniae: case report and review of the literature. J Infect 42(4):272–277CrossRefPubMed
8.
Van der Straeten C, Wei N, Rothschild J, Goozh JL, Klippel JH (1987) Rapidly fatal pneumococcal septicemia in systemic lupus erythematosus. J Rheumatol 14(6):1177–1780PubMed
9.
Peters NS, Eykyn SJ, Rudd AG (1989) Pneumococcal cellulitis: a rare manifestation of pneumococcaemia in adults. J Infect 19(1):57–59CrossRefPubMed
10.
Kwak EJ, McClure JA, McGeer A, Lee BC (2002) Exploring the pathogenesis of necrotizing fasciitis due to Streptococcus pneumoniae. Scand J Infect Dis 34(9):639–644CrossRefPubMed
11.
McEntegart A, Capell HA (2002) Necrotizing fasciitis in a patient with rheumatoid arthritis. Rheumatology (Oxford) 41(7):828–829CrossRef
12.
Mendez EA, Espinoza LM, Harris M, Angulo J, Sanders CV, Espinoza LR (1999) Systemic lupus erythematosus complicated by necrotizing fasciitis. Lupus 8(2):157–159CrossRefPubMed
13.
Hashimoto N, Sugiyama H, Asagoe K, Hara K, Yamasaki O, Yamasaki Y et al (2002) Fulminant necrotising fasciitis developing during long term corticosteroid treatment of systemic lupus erythematosus. Ann Rheum Dis 61(9):848–849CrossRefPubMed
14.
DiNubile MJ, Albornoz MA, Stumacher RJ, Van Uitert BL, Paluzzi SA, Bush LM et al (1991) Pneumococcal soft-tissue infections: possible association with connective tissue diseases. J Infect Dis 163(4):897–900PubMed
15.
16.
Noel V, Lortholary O, Casassus P, Cohen P, Genereau T, Andre MH et al (2001) Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 60(12):1141–1144CrossRefPubMed
Metadata
Title
Necrotizing fasciitis resulting from Streptococcus pneumoniae in recently diagnosed systemic lupus erythematosus case: a case report
Authors
A. Isik
S. S. Koca
Publication date
01-06-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 6/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0234-1

Other articles of this Issue 6/2007

Clinical Rheumatology 6/2007 Go to the issue

Case Report

Leukocytapheresis for the treatment of refractory systemic-onset juvenile idiopathic arthritis

Original Article

Clinical features, prognostic and risk factors of central nervous system infections in patients with systemic lupus erythematosus

Case Report

Subcutaneous infection with Pseudallescheria boydii in an immunocompromised patient

Original Article

Response to one infusion predicts subsequent improvement as well as the rate of relapse of ankylosing spondylitis infused with three pulses of infliximab

Original Article

Multislice CT pulmonary findings in Behçet’s disease (Report of 16 cases)

Brief Report

Mutations of activin-receptor-like kinase 1 (ALK-1) are not found in patients with pulmonary hypertension and underlying connective tissue disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits